Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

Share Price is delayed by 15 minutes
Get Live Data
1,811.00    -122.00 (-6.31%)
Bid:
1,821.50
Ask:
1,822.50
Spread: 1.00 (0.055%)
Market Cap: £39.52b
STAN Live PriceLast checked at - London Stock Exchange

Intraday Standard Chartered Share Chart

Presentation of Financial Information

25 Jul 2023 09:50

RNS Number : 1103H
Standard Chartered PLC
25 July 2023
 

 

STANDARD CHARTERED PLC

PRESENTATION OF FINANCIAL INFORMATION

25th July 2023

 

Standard Chartered PLC (the Group) is reclassifying certain interest expenses and fees between Net Interest Income and Other Income to align with the way it manages its business and the basis on which it already calculates Net Interest Margin; there is no change to total Underlying Income.

 

The interest expense associated with funding the trading book will in future be deducted from Other Income rather than Net Interest Income. Recent rises in interest rates have materially increased the size of this adjustment, up from $462 million in 2022 to a guided $1.7 billion in 2023, making a change in definition more appropriate than continuous adjustment.

 

And financial guarantee fees in relation to interest-earning assets will in future be reported in Underlying Net Interest Income rather than within Underlying Other Income.

 

These changes will mean that the Group's Underlying Net Interest Income can be derived simply from the Net Interest Margin and balance sheet amounts without the need for further adjustments.

 

These adjustments will not be made for the purposes of the statutory Net Interest Income and statutory Other Income disclosures.

 

The table below reconciles the Group's revised Underlying Net Interest Income and Underlying Other Income on the new basis of preparation from the previously reported disclosures.

 

 

 

 

 

2Q'22

 

1H'22

 

FY'22

 

1Q'23

 

Old Definition of Underlying Net Interest Income

 

1,852

 

3,635

 

7,584

 

2,007

 

Trading Book Funding Cost Adjustment

65

106

463

352

Financial guarantee fees in relation to interest-earning assets

(27)

(47)

(80)

(18)

Revised Definition of Underlying Net Interest Income

 

1,890

 

3,694

 

7,967

 

2,341

Old Definition of Underlying Other Income

 

1,931

 

4,224

 

8,178

 

2,389

 

Trading Book Funding Cost Adjustment

(65)

(106)

(463)

(352)

Financial guarantee fees in relation to interest-earning assets

27

47

80

18

Revised Definition of Underlying Other Income

 

1,893

 

4,165

 

7,795

 

2,055

Old Definition of Underlying Operating Income

 

3,783

 

7,859

 

15,762

 

4,396

 

Revised Definition of Underlying Operating Income

 

3,783

 

7,859

 

15,762

 

4,396

 

Net Change

 

0

 

0

 

0

 

0

 

 

The re-presentations summarised above have not resulted in any changes to the reported income or balances in total at a Group level.

The financial results for the first half of 2023, which will be announced on Friday 28 July 2023, will be presented on this new basis.

The latest company-compiled consensus has been republished incorporating the updated definition of underlying net interest income and other income and can be found here.

Ends

For further information, please contact:

Gregg Powell, Group Head, Investor Relations: +44 (0) 20 7885 5172

Adnan Akhtar, Head of Sell-Side, Investor Relations: +44 (0) 20 7885 7255

Shaun Gamble, Executive Director, Media Relations: +44 (0) 20 7885 5934

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGIGDRLSDDGXU
Date   Source Headline
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202610:32 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSIssuance of Additional Tier 1 Securities
28th May 20264:40 pmRNSAdmission to Trading & Publication of Final Terms
28th May 20264:04 pmRNSAdmission to Trading & Publication of Final Terms
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSStandard Chartered Investor Event 2026 Day 2
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20263:00 pmRNSDirector/PDMR Shareholding
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20262:50 pmRNSPublication of Supplementary Prospectus
19th May 20267:00 amRNSStandard Chartered targets ~ 18% RoTE in 2030
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:10 amRNSTransaction in Own Shares
18th May 20267:00 amRNSDirectorate and Group Management Team Changes
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20262:56 pmRNSResult of AGM
7th May 202611:04 amRNSAGM Statement
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20265:58 pmRNSTransaction in Own Shares
1st May 202611:46 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 202612:40 pmRNSPublication of a Supplementary Prospectus
30th Apr 202610:13 amRNSQ1 2026 Pillar 3 Disclosures
30th Apr 20267:05 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNS1st Quarter Results
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20262:45 pmRNSPublication of a Prospectus
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.